We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

328 hedge funds and large institutions have $12B invested in Karuna Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 110 funds opening new positions, 105 increasing their positions, 87 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more funds holding in top 10

Funds holding in top 10: 6 → 26 (+20)

206% more first-time investments, than exits

New positions opened: 110 | Existing positions closed: 36

87% more capital invested

Capital invested by funds: $6.46B → $12B (+$5.59B)

28% more funds holding

Funds holding: 256 → 328 (+72)

21% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 87

20% more call options, than puts

Call options by funds: $277M | Put options by funds: $231M

Holders
328
Holders Change
+72
Holders Change %
+28.13%
% of All Funds
4.78%
Holding in Top 10
26
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+333.33%
% of All Funds
0.38%
New
110
Increased
105
Reduced
87
Closed
36
Calls
$277M
Puts
$231M
Net Calls
+$46.5M
Net Calls Change
+$66.7M

Top Buyers

1
PCM
Pentwater Capital Management
Florida
+$202M
2
HI
HBK Investments
Texas
+$124M
3
FCM
Farallon Capital Management
California
+$101M
4
UBS Group
UBS Group
Switzerland
+$81.5M
5
WP
Woodline Partners
California
+$65.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$541M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$191M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$150M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$55M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$43.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital International Investors
1
Capital International Investors
California
$1.34B +$46M +236,491 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.02B +$4.12M +21,201 +0.7%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$907M -$541M -2,784,173 -49%
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$858M -$6.38M -32,828 -1%
BlackRock
5
BlackRock
New York
$638M +$10.2M +52,457 +3%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$621M -$150M -773,251 -28%
SI
7
Sofinnova Investments
California
$437M – – –
Wellington Management Group
8
Wellington Management Group
Massachusetts
$359M -$29.4M -151,462 -12%
PCM
9
Pentwater Capital Management
Florida
$337M +$202M +1,037,700 +3,641%
GA
10
General Atlantic
New York
$312M – – –
State Street
11
State Street
Massachusetts
$308M +$8.88M +45,673 +5%
PBPIA
12
Pivotal bioVenture Partners Investment Advisor
California
$252M – – –
HI
13
HBK Investments
Texas
$201M +$124M +635,960 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$180M +$4.79M +24,649 +5%
FCM
15
Farallon Capital Management
California
$165M +$101M +519,800 +23,627%
RSCM
16
Rock Springs Capital Management
Maryland
$163M +$1.86M +9,591 +2%
UBS Group
17
UBS Group
Switzerland
$134M +$81.5M +419,217 +14,158%
AllianceBernstein
18
AllianceBernstein
Tennessee
$119M +$2.68M +13,787 +4%
WP
19
Woodline Partners
California
$113M +$65.1M +334,751 +1,473%
Brown Advisory
20
Brown Advisory
Maryland
$105M +$2.15M +11,059 +3%
Norges Bank
21
Norges Bank
Norway
$104M -$389K -2,002 -0.6%
Invesco
22
Invesco
Georgia
$101M -$8.94M -45,998 -13%
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$100M +$40.4M +208,093 +193%
Morgan Stanley
24
Morgan Stanley
New York
$98.8M +$50.6M +260,397 +504%
FLAM
25
First Light Asset Management
Minnesota
$90.9M -$3.13M -16,100 -5%
1
2 3 4 5

KRTX Hedge Fund Activity: Q4 2023 in Review

328 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q4 2023, worth a combined $12B — up 87% from $6.46B a quarter earlier.

Buyers outnumbered sellers: 110 funds opened new KRTX positions and 36 closed out — a net gain of 74 holders — while 105 added to existing stakes and 87 trimmed.

The largest buyer was Pentwater Capital Management, adding an estimated $202M. The largest seller was Fidelity Investments, cutting an estimated $541M.

  • 328 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q4 2023, up from 256 in Q3 2023.
  • Funds reported $12B of Karuna Therapeutics, Inc. Common Stock stock for Q4 2023, up 87% quarter-over-quarter.
  • 110 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q4 2023 and 36 closed out, a net change of +74 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q4 2023 was Pentwater Capital Management, an estimated $202M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $541M sold.

Based on aggregated 13F filings for Q4 2023.